Sector revisions Becton, Dickinson and Company

Equities

Market Closed - Nyse Other stock markets 01:30:03 18/04/2026 am IST			5-day change	1st Jan Change
158.54 ^USD	+2.40%		+2.80%	-18.31%

17/04	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
14/04	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
BECTON, DICKINSON AND COMPANY			13
ABBOTT LABORATORIES			25
MEDTRONIC PLC			25
CENCORA, INC.			12
HOYA CORPORATION			15
MEDLINE INC.	-	-	27
DEXCOM, INC.			24
STERIS PLC			7
SARTORIUS STEDIM BIOTECH			14
TERUMO CORPORATION			13
WEST PHARMACEUTICAL SERVICES, INC.			13
ZIMMER BIOMET HOLDINGS, INC.			21
INSULET CORPORATION			23
ALIGN TECHNOLOGY, INC.			14
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED			13
GLOBUS MEDICAL, INC.			12
SOLVENTUM CORPORATION			12
BAXTER INTERNATIONAL INC.			13
BIO-RAD LABORATORIES, INC.			4
DEMANT A/S			18
Average			16
Weighted average by Cap.			19